ImmunityBio Inc (NASDAQ: IBRX) is -25.90% lower on its value in year-to-date trading and has touched a low of $1.25 and a high of $10.53 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IBRX stock was last observed hovering at around $3.65 in the last trading session, with the day’s gains setting it 0.07%.
Currently trading at $3.72, the stock is 5.06% and -1.69% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.86 million and changing 1.92% at the moment leaves the stock -27.97% off its SMA200. IBRX registered 190.62% gain for a year compared to 6-month loss of -29.01%. The firm has a 50-day simple moving average (SMA 50) of $3.7838 and a 200-day simple moving average (SMA200) of $5.164525.
The stock witnessed a 3.91% gain in the last 1 month and extending the period to 3 months gives it a -41.87%, and is 6.59% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.47% over the week and 6.34% over the month.
ImmunityBio Inc (IBRX) has around 628 employees, a market worth around $2.59B and $1.31M in sales. Profit margin for the company is -45691.67%. Distance from 52-week low is 197.60% and -64.67% from its 52-week high. The company has generated returns on investments over the last 12 months (-203.07%).
The EPS is expected to grow by 25.22% this year.
ImmunityBio Inc (IBRX) Top Institutional Holders
258.0 institutions hold shares in ImmunityBio Inc (IBRX), with institutional investors hold 39.84% of the company’s shares. The shares outstanding are 670.87M, and float is at 159.51M with Short Float at 33.02%. Institutions hold 9.15% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 13.83 million shares valued at $87.42 million. The investor’s holdings represent 2.0558% of the IBRX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.42 million shares valued at $72.19 million to account for 1.6978 of the shares outstanding. The other top investors are STATE STREET CORP which holds 7.86 million shares representing 1.1688% and valued at over $49.7 million, while GEODE CAPITAL MANAGEMENT, LLC holds 0.5822 of the shares totaling 3.92 million with a market value of $24.76 million.
ImmunityBio Inc (IBRX) Insider Activity
#####
